guidelines:
  1: HAS-BLED_Assessment.v1
test_cases:
- id: 0
  input:
    1:
      gt0003|Total score: 0
  expected_output:
    1:
      gt0005|HAS-BLED Risk assessment: 0|local::at0003|Low risk |
      gt0007|Recommendation: 0|local::at0018|Anticoagulation should be considered|
      gt0006|Percentage Bleeding risk per 100 patient-year: 0|local::at0015|(0.6-1.13%)|
- id: 1
  input:
    1:
      gt0003|Total score: 1
  expected_output:
    1:
      gt0005|HAS-BLED Risk assessment: 1|local::at0004|Intermediate risk |
      gt0007|Recommendation: 1|local::at0019|Anticoagulation can be considered|
      gt0006|Percentage Bleeding risk per 100 patient-year: 1|local::at0016|(1.02-3.2%)|
- id: 2
  input:
    1:
      gt0003|Total score: 2
  expected_output:
    1:
      gt0005|HAS-BLED Risk assessment: 1|local::at0004|Intermediate risk |
      gt0007|Recommendation: 1|local::at0019|Anticoagulation can be considered|
      gt0006|Percentage Bleeding risk per 100 patient-year: 1|local::at0016|(1.02-3.2%)|
- id: 3
  input:
    1:
      gt0003|Total score: 3
  expected_output:
    1:
      gt0005|HAS-BLED Risk assessment: 2|local::at0006|High risk |
      gt0007|Recommendation: 2|local::at0020|Alternatives to anticoagulation should be considered|
      gt0006|Percentage Bleeding risk per 100 patient-year: 2|local::at0017|(4.9-19.6%) |
